Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) EBIT (2017 - 2025)

Historic EBIT for ENvue Medical (FEED) over the last 11 years, with Q3 2025 value amounting to -$2.2 million.

  • ENvue Medical's EBIT fell 13164.95% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 22412.49%. This contributed to the annual value of -$3.6 million for FY2024, which is 424.91% down from last year.
  • Per ENvue Medical's latest filing, its EBIT stood at -$2.2 million for Q3 2025, which was down 13164.95% from -$4.0 million recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's EBIT ranged from a high of -$568000.0 in Q1 2024 and a low of -$4.0 million during Q2 2025
  • Over the past 5 years, ENvue Medical's median EBIT value was -$1.1 million (recorded in 2023), while the average stood at -$1.4 million.
  • In the last 5 years, ENvue Medical's EBIT soared by 5889.93% in 2023 and then crashed by 48991.1% in 2025.
  • ENvue Medical's EBIT (Quarter) stood at -$2.5 million in 2021, then soared by 31.95% to -$1.7 million in 2022, then surged by 58.9% to -$702000.0 in 2023, then tumbled by 95.16% to -$1.4 million in 2024, then plummeted by 64.01% to -$2.2 million in 2025.
  • Its EBIT stands at -$2.2 million for Q3 2025, versus -$4.0 million for Q2 2025 and -$1.9 million for Q1 2025.